PORTAGE ANNOUNCES FILING OF Q1 INTERIM FINANCIAL STATEMENTS; CORRECTION TO SALVARX LOAN NOTE SETTLEMENT ANNOUNCEMENT Press ReleaseBy Portage Biotech, IncOctober 16, 2020...
PORTAGE ISSUES COMMON SHARES AND WARRANTS IN SETTLEMENT OF SALVARX LOAN NOTE OBLIGATIONS Press ReleaseBy Portage Biotech, IncOctober 13, 2020...
PORTAGE ANNOUNCES RELIANCE ON TEMPORARY REGULATORY RELIEF FOR FILING ANNUAL FINANCIAL STATEMENTS Press ReleaseBy Portage Biotech, IncJuly 28, 2020...
PORTAGE ANNOUNCES RESULTS OF ANNUAL MEETING; PRIVATE PLACEMENT UPDATE; CORPORATE UPDATE Press ReleaseBy Portage Biotech, IncJune 26, 2020...
PORTAGE RAISES MORE THAN US$6.7 MILLION THROUGH NON-BROKERED PRIVATE PLACEMENT; TEMPORARY SYMBOL CHANGE ON OTC MARKETS Press ReleaseBy Portage Biotech, IncJune 16, 2020...
PORTAGE ANNOUNCES SHARE CONSOLIDATION (REVERSE SPLIT) EFFECTIVE DATE Press ReleaseBy Portage Biotech, IncJune 3, 2020...
Portage is pleased to announce the appointment of Allan L. Shaw as CFO Press ReleaseBy Portage Biotech, IncMay 12, 2020...
PORTAGE MAKES ADDITIONAL INVESTMENT IN STIMUNITY S.A.S, A PARIS-BASED CANCER IMMUNOTHERAPY COMPANY. Press ReleaseBy Portage Biotech, IncMay 11, 2020...
Portage makes an additional investment in Saugatuck therapeutics after achieving proof of concept Press ReleaseBy Portage Biotech, IncMay 5, 2020...
